273 related articles for article (PubMed ID: 9425600)
1. The P-glycoprotein efflux pump: how does it transport drugs?
Sharom FJ
J Membr Biol; 1997 Dec; 160(3):161-75. PubMed ID: 9425600
[TBL] [Abstract][Full Text] [Related]
2. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
[TBL] [Abstract][Full Text] [Related]
3. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 2001 Jun; 40(23):6937-47. PubMed ID: 11389609
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of P-glycoprotein in relation to passive membrane permeation.
Eytan GD; Kuchel PW
Int Rev Cytol; 1999; 190():175-250. PubMed ID: 10331240
[TBL] [Abstract][Full Text] [Related]
5. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.
Ruth A; Stein WD; Rose E; Roninson IB
Biochemistry; 2001 Apr; 40(14):4332-9. PubMed ID: 11284689
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
Eckford PD; Sharom FJ
Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity.
Mechetner EB; Schott B; Morse BS; Stein WD; Druley T; Davis KA; Tsuruo T; Roninson IB
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):12908-13. PubMed ID: 9371774
[TBL] [Abstract][Full Text] [Related]
8. Drug-stimulated ATPase activity of the human P-glycoprotein.
Scarborough GA
J Bioenerg Biomembr; 1995 Feb; 27(1):37-41. PubMed ID: 7629050
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution and functional studies of hamster P-glycoprotein in giant liposomes.
Park S; Majd S
PLoS One; 2018; 13(6):e0199279. PubMed ID: 29912971
[TBL] [Abstract][Full Text] [Related]
10. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
Borgnia MJ; Eytan GD; Assaraf YG
J Biol Chem; 1996 Feb; 271(6):3163-71. PubMed ID: 8621716
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of action of multidrug-resistance-linked P-glycoprotein.
Sauna ZE; Smith MM; Müller M; Kerr KM; Ambudkar SV
J Bioenerg Biomembr; 2001 Dec; 33(6):481-91. PubMed ID: 11804190
[TBL] [Abstract][Full Text] [Related]
12. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells.
Regev R; Assaraf YG; Eytan GD
Eur J Biochem; 1999 Jan; 259(1-2):18-24. PubMed ID: 9914470
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.
Di Pietro A; Dayan G; Conseil G; Steinfels E; Krell T; Trompier D; Baubichon-Cortay H; Jault J
Braz J Med Biol Res; 1999 Aug; 32(8):925-39. PubMed ID: 10454753
[TBL] [Abstract][Full Text] [Related]
14. Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.
Sharom FJ; Yu X; DiDiodato G; Chu JW
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):421-8. PubMed ID: 8973548
[TBL] [Abstract][Full Text] [Related]
15. Conformational changes of P-glycoprotein by nucleotide binding.
Wang G; Pincheira R; Zhang M; Zhang JT
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):897-904. PubMed ID: 9396736
[TBL] [Abstract][Full Text] [Related]
16. The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids.
Romsicki Y; Sharom FJ
Eur J Biochem; 1998 Aug; 256(1):170-8. PubMed ID: 9746361
[TBL] [Abstract][Full Text] [Related]
17. About a switch: how P-glycoprotein (ABCB1) harnesses the energy of ATP binding and hydrolysis to do mechanical work.
Sauna ZE; Ambudkar SV
Mol Cancer Ther; 2007 Jan; 6(1):13-23. PubMed ID: 17237262
[TBL] [Abstract][Full Text] [Related]
18. Daunorubicin efflux against a concentration gradient in non-P-glycoprotein multidrug-resistant lung-cancer cells.
Mülder HS; Lankelma J; Dekker H; Broxterman HJ; Pinedo HM
Int J Cancer; 1994 Oct; 59(2):275-81. PubMed ID: 7927929
[TBL] [Abstract][Full Text] [Related]
19. Lipid bilayer properties control membrane partitioning, binding, and transport of p-glycoprotein substrates.
Clay AT; Sharom FJ
Biochemistry; 2013 Jan; 52(2):343-54. PubMed ID: 23268645
[TBL] [Abstract][Full Text] [Related]
20. Drug-Induced Conformational Dynamics of P-Glycoprotein Underlies the Transport of Camptothecin Analogs.
Mensah GAK; Schaefer KG; Bartlett MG; Roberts AG; King GM
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
